- Home
- / UNITY Biotechnology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
UNITY Biotechnology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.4
2024-10-29
Market Capitalization
$23.6 M
2024-10-29
Revenue
$236 K
FY, 2022
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.8M | 236.0K | |||||
| General and administrative expense | 16.0M | 20.0M | 24.0M | 23.1M | 20.9M | 19.0M | 15.5M |
| Operating expense total | 74.9M | 91.0M | 91.3M | 57.8M | 28.5M | ||
| EBIT | (79.5M) | (89.7M) | (93.9M) | (56.7M) | (57.6M) | (44.7M) | (31.2M) |
| EBIT margin, % | -24394.9% | ||||||
| Interest expense | 3.3M | 3.3M | 1.2M | 100.0K | 1.2M | 2.5M | |
| Net Income | (76.4M) | (82.2M) | (93.9M) | (60.8M) | (59.9M) | (39.9M) | (26.0M) |
| EPS | (6.3) | (2.0) | (1.5) |